![](/img/cover-not-exists.png)
PCVII COST EFFECTIVENESS OF ADDING NIASPANTO ATORVASTATIN TREATMENT IN THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN PATIENTS WITH DYSLIPIDEMIA IN THE UK
W Berger, S Roze, WJ Valentine, AJ PalmerVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65793-2
File:
PDF, 66 KB
english, 2004